
zzso and zzso zzso are analgesics of step 2 WHO zzso zzso zzso for mild to moderate pain, weak zzso frequently used in the treatment of cancer pain of moderate zzso The aim of the study was to assess the impact of zzso and zzso treatment on quality of life zzso and performance status zzso of patients with cancer zzso 

zzso zzso clinical study of 40 zzso patients with zzso cancer pain who received zzso or zzso controlled release zzso for 7 days, and then drugs were switched and administered for another 7 zzso zzso was assessed by visual analogue scale zzso zzso by zzso zzso C 30, and zzso by Eastern Cooperative Oncology Group zzso and zzso 

From 40 patients zzso 30 completed the zzso zzso treatment provided better analgesia zzso In zzso functional zzso better emotional functioning in zzso group and better global zzso and cognitive functioning in zzso group were zzso In symptom zzso less fatigue, pain and sleep zzso less zzso and vomiting and better appetite in zzso group were zzso In zzso group, less zzso and less financial problems were zzso No differences in zzso and zzso were zzso zzso and zzso zzso were low and did not differ between zzso and zzso zzso 

zzso treatment was associated with better global zzso cognitive zzso analgesia and zzso less fatigue, sleep zzso zzso and zzso zzso therapy was connected with better emotional zzso less zzso and financial zzso zzso deteriorated in both zzso and zzso zzso 

